Reuters Health News Summary

Following is a summary of current health news briefs. Women often keep impact of menstrual pain, bleeding to themselves

Many women who suffer from menstrual symptoms like pain and heavy bleeding don't tell their families or doctors about it even when it interferes with their ability to keep up with daily routines, a Dutch study suggests. Among nearly 43,000 girls and women who responded to an online nationwide survey, 85 percent said they experienced painful cramping during their periods, 77 percent had symptoms of mood disorders, and 71 percent suffered from tiredness or exhaustion. New nursing home patients may wait to see a doctor

When Medicare patients are discharged from a hospital to a skilled nursing facility, the time it takes for a doctor or advanced-level practitioner to see them for a first evaluation can vary widely, a new study suggests. About one in six initial medical assessments occur more than four days after nursing home admission, for example, and one in 10 patients never get such an assessment during their nursing home stay, according to the report in Health Affairs. Drugmakers Jazz, Alexion, Lundbeck to pay $123 million to resolve U.S. charity kickback probe

Three drugmakers will pay $122.6 million to resolve claims they used charities that help cover Medicare patients' out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging use of their medications, including some expensive ones. The U.S. Justice Department on Thursday said Jazz Pharmaceuticals Plc, Lundbeck and Alexion Pharmaceuticals Inc were the latest companies to settle claims stemming from an industry-wide probe of drugmakers' financial support of patient assistance charities. Health Canada plans to suspend Allergan's breast implant license

Health Canada plans to suspend the license for Allergan Plc's Biocell breast implant due to the risk of a rare cancer linked to such implants, the regulator said in a notice to the Botox-maker on Thursday. Breast augmentation using implants is a popular form of cosmetic surgery but regulators are studying textured implants, which have a rough surface, and their possible link to anaplastic large cell lymphoma (ALCL). Hospital staff errors with gowns and gloves spread bacteria

Healthcare workers caring for infectious patients sometimes make mistakes when removing personal protective garments, resulting in contamination of clothes or equipment with antibiotic-resistant bacteria, a small study shows. "No one is perfect and inadvertent healthcare worker contamination with multi-drug resistant organisms can occur and may be a key step in the spread of potential pathogens in healthcare settings," said lead study author Dr. Koh Okamoto of Rush University Medical Center in Chicago. Workplace yoga can indeed lower employee stress

People who get to do yoga at work may be less stressed out than their peers who don't, a research review suggests. At any given time, as many as one in six working people suffer from stress and other symptoms related to mental illness, researchers note in Occupational Medicine. Yoga is one of many approaches a growing number of employers are using to combat stress and improve workers' mental health, but research to date has offered a mixed picture of how well these efforts are working. Novartis, Amgen in dispute over migraine drug partnership

Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to wrongfully back out of agreements to jointly develop and market the migraine prevention drug Aimovig and keep the profits for itself. The complaint filed in the U.S. District Court in Manhattan comes as drugmakers move to build share in the large market for new treatments to prevent migraine headaches. Oklahoma drops several claims in opioid case against J&J, Teva

Oklahoma's attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd in a closely watched lawsuit alleging the drugmakers helped fuel the U.S. opioid epidemic. The move by Oklahoma Attorney General Mike Hunter came ahead of an upcoming May 28 trial, the first in the United States to result from roughly 2,000 lawsuits seeking to hold manufacturers of painkillers responsible for contributing to the epidemic. Drug company founder, execs exploited patients to sell opioid: U.S. prosecutor

The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray, fueling the U.S. opioid epidemic, a federal prosecutor said on Thursday at the end of a landmark trial. John Kapoor, the drugmaker's former chairman, and four colleagues are the first executives of a painkiller manufacturer to face trial for conduct that authorities say was tied to a drug abuse epidemic that kills tens of thousands of Americans each year. CDC investigates E.coli outbreak in several states

The Centers for Disease Control and Prevention (CDC) and several other U.S. agencies are investigating an E.coli outbreak in five states, the CDC said https://www.cdc.gov/ecoli/2019/o103-04-19/map.html on Friday. The CDC, the U.S. Department of Agriculture's Food Safety and Inspection Service, the U.S. Food and Drug Administration and several states are investigating the outbreak of toxin-producing E.coli O103 infections.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)